Importantly, localized increases in GLP-1, such as that occur in the gut and portal vein, often have a more profound effect than systemic elevations, emphasizing the therapeutic potential of targeting regional activity rather than relying solely on systemic concentrations
The most definitive indicator is consistent on-target toxicity at therapeutically relevant exposure levels
Telehealth care is ideal for adults who want consistent care with the flexibility of remote access
Wegovy works by mimicking a hormone called GLP-1, which targets areas of the brain involved in regulating appetite
J Diabetes Investig (2010) 1:823
Glucagon-like peptide-1 (GLP-1) receptor agonists are a class of medications primarily licensed for the management of type 2 diabetes mellitus and, in specific cases, for weight management